Obesity or Overweight, research hub

A Phase III Randomised, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 in Participants with Obesity or Overweight With at Least One Weight Related Comorbidity Without Type 2 Diabetes Mellitus

This clinical trial is testing a new medicine called AZD6234 for adults who are overweight or living with obesity. Researchers want to see if the drug helps people lose weight safely over 68 weeks, compared with a dummy treatment, in people who do not have type 2 diabetes.